Description
A uricosuric agent that competitively inhibits uric acid reabsorption in kidney proximal tubules, which is a key mechanism targeted in the treatment of gout; inhibits degranulation of platelets, reducing the release of ADP and thromboxane and diminishing platelet aggregation
Formal name: 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-3,5-pyrazolidinedione
Synonyms: G-28315|NSC 75925
Molecular weight: 404.5
CAS: 57-96-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Cardiovascular System|Blood|Coagulation & Hemostasis||Research Area|Immunology & Inflammation|Arthritis (Non-autoimmune)